Почетна › Рак на дојка › Тенеси › Memphis
Клинички испитувања за Рак на дојка во Memphis, TN
22 студии за Рак на дојка бараат учесници на локации во и околу Memphis (во радиус од околу 30 милји). Отворете ја студијата за да видите кој може да учествува и како да го контактирате тимот.
Официјален текст на студијата (англиски)
Барате учесници за студија? Истакнете ја на врвот од оваа страница — $99 за 30 дена →
A Study of Patritumab Deruxtecan (HER3-DXd) in Combination With Trastuzumab Deruxtecan (T-DXd) in Participants With HR-Positive, HER2-Low or HER2-Ultralow Unresectable or Metastatic Breast Cancer
Се регрутираФаза 1/2
- The West Cancer Center, Memphis
Beamion BCGC-1: A Study to Find a Suitable Dose of Zongertinib Used Alone and in Combination With Other Treatments to Test Whether it Helps People With Different Types of HER2+ Cancer That Has Spread
Се регрутираФаза 1/2
- Baptist Cancer Center - Memphis, Memphis
The CDK4/6 Inhibitor Dosing Knowledge (CDK) Study
Се регрутираФаза 3
- Baptist Memorial Healthcare, Memphis
A Study to Test Inavolisib Treatments in Participants With Early-Stage, PIK3CA-Mutated Breast Cancer
Се регрутираФаза 2
- West Cancer Center, Germantown · на 14 милји
Signatera-Guided CDK4/6 Inhibitor Therapy in Breast Cancer
Се регрутира
- West Cancer Center, Germantown · на 14 милји
Palazestrant in Combination With Ribociclib for the First-line Treatment of ER+/HER2- Advanced Breast Cancer
Се регрутираФаза 3
- Clinical Trial Site, Bartlett · на 11 милји
ROSETTA Breast-01: The Effects and Safety of Pumitamig in Patients With Triple-Negative Breast Cancer
Се регрутираФаза 3
- The West Clinic, P.C. dba West Cancer Center, Germantown · на 14 милји
A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence
Се регрутираФаза 3
- Baptist Cancer Center, Memphis
A Study Evaluating the Efficacy and Safety of Multiple Treatment Combinations in Patients With Metastatic or Locally Advanced Breast Cancer
Се регрутираФаза 1/2
- The West Clinic, Germantown · на 14 милји
Post-Marketing Study for Early-Stage Low-Risk Breast Cancer Treatment Using ProSense® Cryoablation (ChoICE Trial)
Се регрутира
- The West Clinic, PC dba West Cancer Center, Germantown · на 14 милји
A Study Evaluating the Efficacy and Safety of Inavolisib Plus CDK4/6 Inhibitor and Letrozole vs Placebo + CDK4/6i and Letrozole in Participants With Endocrine-Sensitive PIK3CA-Mutated, Hormone Receptor-Positive, HER2-Negative Advanced Breast Cancer
Се регрутираФаза 3
- West Cancer Center, Germantown · на 14 милји
Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25
Се регрутираФаза 3
- Baptist Memorial Hospital and Cancer Center-Memphis, Memphis
- Baptist Memorial Hospital and Cancer Center-Desoto, Southhaven · на 12 милји
- The West Clinic - Wolf River, Germantown · на 14 милји
- и уште 1
E-Mindfulness Approaches for Living After Breast Cancer
Се регрутираФаза 3
- Baptist Memorial Hospital and Cancer Center-Memphis, Memphis
- Baptist Memorial Hospital and Cancer Center-Desoto, Southhaven · на 12 милји
First-in-Human Study of Tersolisib (STX-478) as Monotherapy and in Combination With Other Antineoplastic Agents in Participants With Advanced Solid Tumors
Се регрутираФаза 1/2
- The West Clinic, PLLC dba West Cancer Center, Germantown · на 14 милји
Familial Investigations of Childhood Cancer Predisposition
Се регрутираНабљудувачка студија
- St. Jude Children's Research Hospital, Memphis
A Study to Learn About the Study Medicine Called PF-07248144 in Combination With Fulvestrant in People With HR-positive, HER2-negative Advanced or Metastatic Breast Cancer Who Progressed After a Prior Line of Treatment.
Се регрутираФаза 3
- The West Clinic, PLLC dba West Cancer Center, Germantown · на 14 милји
Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics
Се регрутираНабљудувачка студија
- Baptist Memorial Hospital and Cancer Center-Memphis, Memphis
- Baptist Memorial Hospital for Women, Memphis
- Baptist Memorial Hospital and Cancer Center-Desoto, Southaven · на 11 милји
- и уште 1
cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease
Се регрутираНабљудувачка студијаДобредојдени се здрави волонтери
- Baptist (BHMCC), Memphis
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Се регрутираНабљудувачка студија
- Massive Bio SYNERGY-AI site, Memphis
S1501 Dual Observational and Randomized Cohort Study of Patients With Metastatic HER-2+ Breast Cancer at Risk of Cardiac Toxicity
Се регрутираФаза 3
- Baptist Memorial Hospital and Cancer Center-Memphis, Memphis
A Phase 1 Study of XL309 (ISM3091) Alone and in Combination in Participants With Advanced Solid Tumors
Се регрутираФаза 1
- Exelixis Clinical Site #11, Germantown · на 14 милји
MammaPrint, BluePrint, and Full-genome Data Linked With Clinical Data to Evaluate New Gene EXpression Profiles
Се регрутираНабљудувачка студија
- West Cancer Center, Germantown · на 14 милји
Испитувања за Рак на дојка во други градови
- New York City, NY136 студии
- Houston, TX126 студии
- Boston, MA112 студии
- Nashville, TN81 студија
- Los Angeles, CA73 студии
- Edison, NJ68 студии
- St. Louis, MO64 студии
- Queens, NY64 студии
- Durham, NC64 студии
- Chicago, IL59 студии
- Philadelphia, PA56 студии
- Dallas, TX55 студии
Други студии во Memphis
- Рак (сите типови)31 студија
- Рак на бели дробови со не-мали клетки23 студии
- Рак на бели дробови18 студии
- Српеста анемија18 студии
- Акутна лимфобластна леукемија16 студии
- Акутна миелоидна леукемија15 студии
- Срцева слабост13 студии
- Сарком на меко ткиво11 студии
- Меланом11 студии
- Рак на простата11 студии
- Колоректален карцином11 студии
- Остеосарком10 студии
Од ClinicalTrials.gov, податоци преземени 6.10.2026. Секоја студија ги поставува своите услови за вклучување; тимот на студијата одлучува кој може да учествува.